| Test Name | Reference Range
|
|
| Acid phosphatase, prostatic, serum | 0 - 0.8 U/L
|
|
| ACTH | 6.0 - 76.0 pg/ml
|
|
| Alanine aminotransferase (ALT), serum
|
| male | 10 - 55 U/L
|
| female | 7 - 30 U/L
|
|
| Albumin, serum | 3.5 - 5.2 g/dl
|
|
| Albumin, CSF | 11 - 48 mg/dl
|
|
| Aldosterone, serum or plasma
|
| Standing (normal salt diet) | 2 to 5 times normal supine
|
| Recumbent (normal salt diet) | 2 - 9 ng/dl
|
|
| Alkaline phosphatase, serum | 45 - 150 U/L
|
|
| Alpha-1-antitrypsin, serum | 100 - 200 mg/dl
|
|
| Alpha-fetoprotein (non-maternal) | <15 ng/ml
|
|
| Ammonia, plasma | 7 - 27 micromol/L
|
|
| Amylase, serum | 30 - 110 U/L
|
|
| Amylase, urine | 0.6 - 12 U/hr
|
|
| Antinuclear antibody | <1:20
|
|
| Aspartate aminotransferase (AST), serum | 14 - 59 U/L
|
|
| B12, serum | 210 - 911 pg/ml
|
|
| Bicarbonate (HCO3), serum | 20 - 29 mmol/L
|
|
| Bilirubin, direct, serum | 0 - 0.3 mg/dl
|
|
| Bilirubin, total, serum | 0.2 - 1.9 mg/dl
|
|
| Bleeding time | 2 - 9 minutes
|
|
| BUN (blood urea nitrogen), serum | 7 - 20 mg/dl
|
|
| CBC (complete blood count)
|
| WBC count, total | 3.6 - 11.2 X 103/cu mm
|
| RBC count, whole blood | 4.22 - 5.79 X 106/cu mm
|
| Hemoglobin, female | 12 - 17 g/d
|
| Hemoglobin, male | 13 - 18 g/dl
|
| Hematocrit, female | 37 - 51 %
|
| Hematocrit, male | 43 - 52 %
|
| Mean corpuscular hemoglobin (MCH) | 27 - 34 pg/cell
|
| Mean corpuscular hemoglobin conc (MCHC) | 31 - 36 g/dl
|
| Mean corpuscular volume (MCV) | 84 - 100 cu microm
|
| Red cell distribution width | 10.8 - 14.1%
|
| Platelet count | 140 - 440 X 103/cu mm
|
|
|
| Differential WBC blood count, adult
|
| Neutrophils | 45 - 79 %
|
| Bands | 0 - 5 %
|
| Lymphocytes | 16 - 47 %
|
| Monocytes | 0 - 9 %
|
| Eosinophils | 0 - 6 %
|
| Basophils | 0 - 3 %
|
|
| Calcium, serum | 8.4 - 10.2 mg/dl
|
|
| Calcium, ionized, serum | 1.11 - 1.30 mmol/L
|
|
| CO2 content, total, serum | 20 - 29 mmol/L
|
|
| CO2, arterial (PaCO2) | 35 - 45 mm Hg
|
|
| Carboxyhemoglobin, whole blood | <5% total Hgb (<0.05 saturation)
|
|
| Carcinoembryonic antigen (CEA), serum | 0.0 - 3.0 ng/ml
|
|
| Catecholamines, urine free (adult)
|
| Epinephrine | 0 - 25 microgm/24hr
|
| Norepinephrine | 0 - 100 microgm/24hr
|
| Dopamine | 60 - 440 microgm/24hr
|
|
| Cerebrospinal fluid (CSF) - adult
|
| albumin | 11 - 48 mg/dl
|
| cell count | 0 - 5 monos
|
| chloride | 118 - 132 mmol/L
|
| glucose | 50 - 75 mg/dl
|
| IgG | 8.0 - 8.6 mg/dl
|
| pressure | 70 - 180 mm water
|
| protein | 15 - 45 mg/dl
|
|
| Ceruloplasmin, serum | 25 - 63 mg/dl
|
|
| Chloride, serum or plasma | 101 - 111 mmol/L
|
|
| Cholesterol, total serum | 100 - 240 mg/dl
|
|
| Cholesterol, HDL, serum (desirable) | 40 - 59 mg/dl
|
|
| Complement C3, serum | 88 - 201 mg/dl
|
|
| Complement C4, serum | 16 - 47 mg/dl
|
|
| Copper, serum | 26 - 190 mcrgm/dl
|
|
| Copper, urine | 3 - 35 mcrgm/dl/day
|
|
| Corticotropin (ACTH), plasma | 6.0 - 76.0 pg/ml
|
|
| Cortisol, plasma
|
| 8 am | 6 - 23 mcrgm/dl
|
| 8 pm | 0 - 9 mcrgm/dl
|
|
| Cortisol, free urine | 20 - 70 microgm/day
|
|
| C-peptide, serum | 0.9 - 3.9 ng/ml
|
|
| C-reactive protein, serum | <0.8 mg/dl
|
|
| Creatine kinase (CK), serum
|
| female | 20 - 180 U/L
|
| male | 20 - 200 U/L
|
|
| Creatine kinase isoenzymes
|
| MB fraction | 0 - 5 microgm/L
|
|
| Creatinine, serum | 0.7 - 1.4 mg/dl
|
|
| d-Dimer screen, plasma | <0.5 microgm/ml
|
|
| Differential WBC blood count, adult
|
| Neutrophils | 45 - 79 %
|
| Bands | 0 - 5 %
|
| Lymphocytes | 16 - 47 %
|
| Monocytes | 0 - 9 %
|
| Eosinophils | 0 - 6 %
|
| Basophils | 0 - 3 %
|
|
| Electrolytes, serum
|
| Sodium | 136 - 144 mmol/L
|
| Potassium | 3.7 - 5.2 mmol/L
|
| Chloride | 101 - 111 mmol/L
|
| CO2 content, total | 20 - 29 mmol/L
|
| Urea nitrogen (BUN) | 7 - 20 mg/dl
|
| Creatinine | 0.7 - 1.4 mg/dl
|
| Glucose, fasting | 64 - 125 mg/dl
|
|
| Erythrocyte count, whole blood
|
| male | 4.5 - 5.3 X 106/cu mm
|
| female | 4.1 - 5.1 X 106/cu mm
|
|
| Erythrocyte sedimentation rate (ESR)
|
| female | 0 - 20 mm/hr
|
| male | 0 - 10 mm/hr
|
|
| Fecal fat (as stearic acid) | 0 - 6 g/day
|
|
| Ferritin, serum
|
| male | 7 - 340 ng/ml
|
| female | 7 - 75 ng/ml
|
|
| Fibrin degradation products, plasma | <2.5 microgm/ml
|
|
| Fibrinogen, plasma | 150 - 350 mg/dl
|
|
| Folate (folic acid), serum | 2.8 - 17.8 ng/ml
|
|
| Gamma-glutamyl transferase (GGT),serum
|
| male | 10 - 70 U/L
|
| female | 10 - 55 U/L
|
|
| Gastrin, serum | 0 - 100 pg/ml
|
|
| Globulin, serum | 2.6 - 4.1 g/dl
|
|
| Glucagon, plasma | 40 - 130 pg/ml
|
|
| Glucose, plasma, fasting | 64 - 125 mg/dl
|
|
| Growth hormone, plasma | 0 - 5 ng/ml
|
|
| Haptoglobin, serum | 16 - 200 mg/dl
|
|
| HCG, serum quantitative
|
| female | 2 - 8 IU/L
|
| male | 0 - 5 IU/L
|
|
| HDL cholesterol, serum (desirable) | >40 - 59 mg/dl
|
|
| Hematocrit (Hct)
|
| female | 37 - 51 %
|
| male | 43 - 52 %
|
|
| Hemoglobin (Hgb)
|
| female | 12 - 17 g/dl
|
| male | 13 - 18 g/dl
|
|
| Hemoglobin A1C | 4.1 - 6.5%
|
|
| Homocysteine, plasma, total
|
| female | 4 - 10 micromol/L
|
| male | 4 - 12 micromol/L
|
|
| Homovanillic acid (HVA), urine | 0 - 15 mg/day
|
|
| Immunoglobulins, quantitative serum
|
| IgA | 68 - 378 mg/dl
|
| IgG | 768 - 1632 mg/dl
|
| IgM | 60 - 263 mg/dl
|
| IgE | 10 - 180 IU/L
|
|
| Insulin, serum or plasma, total | 5 - 35 microU/ml
|
|
| Iron, serum
|
| female | 30 - 160 microgm/mL
|
| male | 50 - 170 microgm/mL
|
|
| Iron binding capacity, serum | 240 - 450 microgm/dl
|
|
| Ketones, serum or urine | negative
|
|
| Lactic acid, plasma | 0.5 - 2.2 mmol/L
|
|
| Lactic dehydrogenase (LDH), serum | 300 - 600 U/L
|
|
| Leukocyte count, total (WBC count) | 4.5 - 11.0 X 103/cu mm
|
|
| Lipase, serum | 30 - 210 U/L
|
|
| LDL cholesterol, serum | <110 mg/dl
|
|
| Lymphocyte subsets (absolute count)
|
| CD4 cells | 440 - 1600/microliter
|
| CD8 cells | 180 - 850/microliter
|
|
| Magnesium, serum | 1.6 - 2.3 mg/dl
|
|
| Mean corpuscular hemoglobin (MCH) | 25 - 35 pg/cell
|
|
| Mean corpuscular hemoglobin concentration
(MCHC) | 32 - 36 g/dl
|
|
| Mean corpuscular volume (MCV) | 84 - 100 fl
|
|
| Metanephrines, urine, adult
|
| metanephrine | 0 - 300 microgm/gm of creatinine
|
| normetanephrine | 0 - 400 microgm/gm of creatinine
|
|
| 5'-Nucleotidase, serum | 0 - 15 U/L
|
|
| Osmolality, serum | 280 - 303 mOsm/kg |
|
|
| Oxygen, arterial (PaO2), room air | 80 - 100 mm Hg
|
|
| Oxygen saturation, arterial | 96 - 100%
|
|
| Parathyroid hormone (intact), serum | 10 - 60 pg/ml
|
|
| Partial thromboplastin time, activated (PTT or
APTT), plasma | 25 - 40 seconds
|
|
| pH, arterial | 7.35 - 7.45 pH
|
|
| Phosphorus, inorganic, serum | 2.6 - 4.5 mg/dl
|
|
| Platelet count | 140 - 440 X 103/cu mm
|
|
| Potassium, serum | 3.7 - 5.2 mmol/L
|
|
| Prolactin, serum | 2 - 26 ng/ml
|
|
| Prostate-specific antigen | 0.0 - 4.0 ng/ml
|
|
| Protein, total, serum | 6.3 - 8.2 g/dl
|
|
| Prothrombin time (PT), plasma | 10.7 - 15.0 seconds
|
|
| RBC count, whole blood | 4.22 - 5.79 X 106/cu
|
|
| Renin activity, plasma, adult
|
| upright | 0.5 - 3.3 ng/mL/hr
|
| supine | 0.2 - 1.6 ng/mL/hr
|
|
| Reticulocyte count | 0.5 - 2.7 % of RBC's
|
|
| Sedimentation rate, erythrocyte (ESR)
|
| female | 1 - 20 mm/hr
|
| male | 1 - 10 mm/hr
|
|
| Sodium, serum | 136 - 144 mmol/L
|
|
| Testosterone, total (morning), serum | 200 - 890 ng/dl
|
|
| Thyroid peroxidase (TPO) antibody, serum | 0.0 - 2.0 IU/ml
|
|
| Thyroid stimulating hormone, serum | 0.4 - 5.0 microU/ml
|
|
| Thyroxine, free, serum | 0.8 - 1.8 ng/dl
|
|
| Thyroxine binding globulin, serum | age & sex dependent
|
|
| Thyroxine, free, index | 1.5 - 3.1
|
|
| Thyroxine, total (T4), serum | 4.5 - 10.9 microgm/dl
|
|
| Transferrin, serum | 212 - 360 mg/dl
|
|
| Triglycerides (fasting), serum | 30 - 250 mg/dl
|
|
| Triiodothyronine, total (T3), serum | 70 - 180 ng/dl
|
|
| Troponin I, serum | <0.4 ng/ml (>2.0 suggests acute MI)
|
|
| Urea nitrogen (BUN), serum | 7 - 20 mg/dl
|
|
| Uric Acid, serum
|
| female | 2.5 - 6.1 mg/dl
|
| male | 3.7 - 8.0 mg/dl
|
|
| Vanillylmandelic acid, urine | 0 - 7 mg/day
|
|
| Viscosity, serum | 1.1 - 1.8 cP
|
|
| Vitamin B12, serum | 210 - 911 pg/ml
|
|
| WBC count, total | 3.6 - 11.2 X 103/cu mm
|
|
|
|